This recent report from The Boyd Company provides a look at operating costs for advanced manufacturing and corporate offices across 60 locations.

This follows a global transaction between GlaxoSmithKline plc, UK (GSK) and Novartis AG, Switzerland (Novartis ... towards renovation of its corporate office into a modern workplace.

The FTSE 100 finished up 103.99 at 8727.28 - a new record closing high. It also hit a new intraday record of 8,767.50 earlier ...

France's CAC 40, which closed with a pronounced loss on Monday, settled lower by 0.12%, while Switzerland's SMI gained ... Ashtead Group, GSK, Hiscox, Smith (DS) and Anglo American Plc also ...

The European stock markets closed mostly higher in Wednesday trading as The Stoxx Europe 600 gained 0.36%, Germany's DAX 40 was up 0.22%, the FTSE 100 in London rose 0.61%, France's CAC 40 was off ...

Switzerland: The Swiss National Science Foundation (grants no 33CSCO-134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, ...

European stock markets rose in Friday trading as the Stoxx Europe gained 1.18%, Germany's DAX increased 0.83%, the FTSE in London climbed 1.38%, France's CAC was up 0.58% and the Swiss Market ...

It was approved in the US with a similar label last year after priority review, becoming the first oral alternative to GSK's injectable ... also been filed with the Swiss Agency for Therapeutic ...

It included two of the March portfolio’s top three holdings: European drugmakers GSK and Sanofi ... in Shanghai in 2021—its first investment office outside of San Francisco.

holds part of a patent for the assessment of dyskinesia (German patent office, 102015220741.2) and received speaker's honoraria from GlaxoSmithKline, Abbvie, UCB, Licher MT and Rölke Pharma, unrelated ...

After calling Rockville, Maryland, home for more than eight years, GSK's vaccine and infectious disease R&D teams are ...

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...